FutureLife’s innovative spirit was on full display at the 40th Annual Meeting of ESHRE in Amsterdam. Our teams from Serpha Pharmacy, Institut Marquès, and Fertility Madrid made significant contributions, showcasing our commitment to advancing reproductive health.
Serpha Pharmacy demonstrated their innovative logistical solutions, highlighting how patients can easily upload their prescriptions to the Serpha website and have their medications delivered to any address in Europe. Attendees were impressed by Serpha’s capability to deliver prescriptions within 24 hours to most locations across Europe. As the partner pharmacy of FutureLife, patients from any of the group’s clinics can expect exceptional pharmaceutical service.
Institut Marquès made a remarkable impact with seven scientific presentations covering IVF and Andrology procedures. Their innovative techniques and research were particularly praised for their success in treating women with early menopause and cancer survivors. The institute’s dedication to pushing the boundaries of reproductive medicine was evident in their well-received presentations and discussions.
Fertility Madrid’s IVF Manager, Mar Belmonte, captivated the audience with her speech about their advanced tagging system, Gidget. This cutting-edge technology ensures accurate sample traceability and minimizes errors, providing an added layer of security and reliability in fertility treatments. The presentation on Gidget highlighted how technological advancements are integral to enhancing patient care and outcomes in reproductive health. Read more about it here.
FutureLife CEO, Francisco Lobbosco, expressed his pride and excitement about the company's achievements at ESHRE 2024: "Our strong presence at ESHRE 2024 underscores our commitment to advancing reproductive science and medicine. The synergy between our clinics such as Institut Marquès, Fertility Madrid and Serpha Pharmacy highlights our dedication to improving patient outcomes. I am incredibly proud to lead such a passionate and talented team at the forefront of reproductive medicine."
FutureLife continues to lead the way in reproductive health, driven by innovation and a relentless commitment to patient care. The success and recognition at ESHRE 2024 are testaments to our dedication and the exceptional work of our teams.